- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 403/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 403/12
Total number of patents in this class: 9532
10-year publication summary
|
703
|
696
|
640
|
665
|
640
|
728
|
714
|
661
|
711
|
182
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
223 |
| Boehringer Ingelheim International GmbH | 4629 |
162 |
| F. Hoffmann-La Roche AG | 7958 |
160 |
| Novartis AG | 11238 |
148 |
| Janssen Pharmaceutica N.V. | 3839 |
139 |
| AstraZeneca AB | 3042 |
128 |
| Vertex Pharmaceuticals Incorporated | 1581 |
105 |
| BASF SE | 19740 |
102 |
| Merck Patent GmbH | 5909 |
102 |
| Merck Sharp & Dohme LLC | 3689 |
86 |
| Genentech, Inc. | 3742 |
84 |
| Hoffmann-La Roche Inc. | 3060 |
83 |
| Takeda Pharmaceutical Company Limited | 2961 |
80 |
| Pfizer Inc. | 3322 |
71 |
| Amgen Inc. | 3779 |
71 |
| Rigel Pharmaceuticals, Inc. | 613 |
71 |
| Gilead Sciences, Inc. | 1879 |
65 |
| Bayer Cropscience AG | 2241 |
59 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
59 |
| AstraZeneca UK Limited | 768 |
57 |
| Other owners | 7477 |